International Business Machines (NYSE:IBM) –
According to the South China Morning Post, IBM has closed its
R&D operations in China, laying off over 1,000 employees due to
geopolitical tensions. The company shut down its labs in Beijing,
Shanghai, and Dalian but stated that it will continue to support
customers in the region. IBM’s sales in China dropped 19.6% in
2023. Shares rose 0.8% in pre-market trading.
Uber Technologies (NYSE:UBER) – Uber was fined
$324 million in the Netherlands for transferring European drivers’
personal data to the U.S., violating EU rules, according to the
DPA. Uber, which has ceased this practice, called the fine unfair
and plans to appeal, citing GDPR compliance. Shares rose 0.7% in
pre-market trading.
Boeing (NYSE:BA) – NASA will return Boeing’s
Starliner capsule, which had defects, to Earth without astronauts
Butch Wilmore and Suni Williams. They will return early next year
on a SpaceX spacecraft. The Starliner, which launched its first
astronauts in June, faced leaks and thruster failures, delaying the
mission. Shares fell 0.7% in pre-market trading.
Intel Corp. (NASDAQ:INTC) – Intel has hired
consultants, including Morgan Stanley, to prepare against potential
activist investor pressures, as reported by CNBC. Shares rose 0.8%
in pre-market trading.
Apple (NASDAQ:AAPL) – Apple plans its biggest
launch event of the year on September 10, where it will unveil new
iPhones, watches, and AirPods, according to Bloomberg. While the
date is not yet confirmed, the products are expected to be
available by September 20. The company is betting on AI upgrades to
attract buyers, despite declining sales in China. According to
Reuters, billionaire Daniel Loeb believes Apple’s stock has the
potential to rise further, especially if the company leverages
artificial intelligence in its iOS operating system. Loeb, whose
Third Point acquired Apple shares in April, sees AI as a
significant opportunity that could boost revenue and profits in the
coming years. He highlights that demand for new iPhones is expected
to grow, as AI features won’t be compatible with previous versions,
and Apple’s App Store could become the leading platform for new AI
applications. Shares rose 0.2% in pre-market trading.
Microsoft (NASDAQ:MSFT),
CrowdStrike (NASDAQ:CRWD) – Microsoft plans to
meet in September with cybersecurity firms, including CrowdStrike,
to discuss how to prevent a repeat of the global July failure that
crippled Windows systems. The meeting, in Seattle, will address
best practices for system updates and access to the Windows kernel,
with government representatives in attendance. Microsoft’s shares
rose 0.2% in pre-market trading, while CrowdStrike’s shares rose
0.7%.
Nvidia (NASDAQ:NVDA) – Nvidia is set to
announce another surge in profits, with revenue doubling due to the
growing adoption of generative AI. Shares have risen more than 160%
this year. Second-quarter revenue is expected to grow 109%,
reaching $28.6 billion, while operating profits could reach $18.7
billion. Investors await updates on AI chips and forecasts for the
rest of the year. Shares rose 0.8% in pre-market trading.
Alphabet (NASDAQ:GOOGL) – A report by Eko
revealed that YouTube’s automated systems are displaying ads from
major brands alongside videos promoting controversial policies from
Project 2025 and election misinformation. Researchers analyzed 11
videos, which included ads from more than 60 global brands, many
with public commitments to diversity. Although some videos may
violate YouTube’s guidelines, the platform only removed ads from
specific videos. YouTube defends its guidelines and claims to offer
advertisers control over where their ads are shown. Shares rose
0.4% in pre-market trading.
Paramount Global (NASDAQ:PARA) – Edgar Bronfman
Jr. is willing to have Shari Redstone remain involved with
Paramount Global if his consortium succeeds in buying the company’s
controlling entity, National Amusements. Bronfman has offered $6
billion to take over Paramount, challenging a planned acquisition
by David Ellison and Skydance Media. The final decision on
Redstone’s role at the company will be up to her. Additionally,
Bronfman plans partnerships with companies like Amazon and Apple to
strengthen Paramount Global’s streaming business, according to
Bloomberg. Shares rose 0.5% in pre-market trading.
Meta Platforms (NASDAQ:META) – Meta canceled
plans to launch a premium mixed reality headset that would have
competed with Apple’s Vision Pro, as reported by The Information.
The device, codenamed La Jolla, was scheduled for 2027 but was
halted after a product review. Despite losses in its Reality Labs
division, responsible for the Quest headsets, CEO Mark Zuckerberg
still bets on the future of augmented and virtual reality. Meta had
also previously halted production of the Quest Pro due to weak
sales and negative reviews. In addition, OpenAI has hired Irina
Kofman, a former Meta executive, to lead strategic initiatives,
strengthening its team with veterans from major tech companies.
Kofman, now reporting to CTO Mira Murati, will initially focus on
safety and preparation. Before joining OpenAI, Kofman was senior
director of product management for generative AI at Meta. Shares
rose 0.3% in pre-market trading.
Spotify (NYSE:SPOT) – Mark Zuckerberg, CEO of
Meta, and Daniel Ek, CEO of Spotify, criticized European
regulations on open-source artificial intelligence (AI), warning
that complex rules could make Europe fall behind. Although Europe
has many open-source developers, fragmented regulation is slowing
innovation. They advocate for clearer and harmonized rules to
support AI growth and prevent Europe from missing a unique
opportunity.
Fox Corp (NASDAQ:FOX) – Prominent Democrats
like Gavin Newsom and Pete Buttigieg are making appearances on Fox
News to reach a broader audience and increase visibility ahead of
elections. According to Bloomberg, Fox is seeking to balance its
image and boost its ratings with the presence of politicians from
different parties.
Starbucks (NASDAQ:SBUX) – After two fires at a
Starbucks construction site in Taos, New Mexico, a builder is once
again trying to construct the city’s first drive-through café,
known for its resistance to large corporations. Local residents
oppose the project, reflecting a history of revolt against outside
influences. Security at the site has been increased, and the
investigation into the fires is ongoing. Shares rose 0.2% in
pre-market trading.
Walmart (NYSE:WMT), JD.com
(NASDAQ:JD) – JD.com faces the challenge of proving its relevance
to investors amid a slowdown in e-commerce in China, intense price
wars, and the exit of Walmart, its largest shareholder. Walmart
sold its $3.74 billion stake, causing JD.com’s shares to drop and
raising concerns about its ability to adapt to these changes.
Walmart’s shares rose 0.1% in pre-market trading, while JD.com’s
shares rose 0.6%.
Halliburton (NYSE:HAL) – Halliburton, a leader
in U.S. oilfield services, suffered a cyberattack and is working
with authorities to assess the impact. The company has shut down
some systems as a precaution and is investigating whether the
incident will affect its business. The attack compromised
operations in Houston but did not affect energy services.
Woodside Energy (NYSE:WDS) – Woodside Energy,
Australia’s largest independent gas producer, will release its
first-half results on August 27. According to Visible Alpha, the
company is expected to face a decline in profits, estimated at
$1.11 billion for the first half, compared to $1.90 billion in the
previous year. Uncertainty over future mergers, after the collapse
of a $52 billion merger with Santos, raises concerns about its
growth strategy.
Rivian Automotive (NASDAQ:RIVN) – A fire
occurred in a parking lot at Rivian’s factory in Normal, Illinois,
damaging several electric vehicles. No injuries were reported, and
the cause is under investigation. The assembly plant was not
affected, and Rivian has not confirmed how many vehicles were
damaged. Vehicle production continues to expand at the facility.
Shares fell 0.1% in pre-market trading.
XPeng (NYSE:XPEV) – The Chinese electric
vehicle manufacturer announced that its CEO, Xiaopeng He, acquired
more than 2 million shares of the company, according to the WSJ.
Shares rose 5.8% in pre-market trading.
Canadian National Railway (NYSE:CNI),
Canadian Pacific Kansas City (NYSE:CP) – The
Canadian Industrial Relations Board ordered an end to strikes at
the country’s largest railroads, ending a service disruption that
threatened the Canadian economy. The decision came after a standoff
between 9,000 Teamsters union members and the railroads CN and
CPKC. The union criticized the decision and plans to appeal. Rail
operations are expected to resume on Monday, but full recovery is
expected to take several weeks. In addition, a union notified
Canadian National Railway of a new imminent strike hours after
operations resumed on Friday, threatening to again paralyze supply
chains today if there was no agreement. The Canadian government
imposed mandatory arbitration to resolve disputes.
Norfolk Southern (NYSE:NSC) – Norfolk Southern
and BNSF Railway have reached provisional five-year collective
bargaining agreements with four unions, guaranteeing average annual
wage increases of 3.5%, plus vacation and health benefit
improvements. The agreements, which cover 30% of Norfolk Southern’s
unionized workforce, still need to be ratified.
Delta Air Lines (NYSE:DAL) – Delta’s Chief
Operating Officer Mike Spanos will leave the company next month to
take another position. Spanos, who joined Delta last year, is
leaving after considering new opportunities. His departure comes
weeks after flight cancellations due to cyber issues. Delta has no
plans to replace him immediately.
Citigroup (NYSE:C) – Citigroup argues that the
firing of Kathleen Martin, a former managing director suing the
bank, was due to performance issues, not her allegations of
covering up information to regulators. Martin claims she was fired
in retaliation for refusing to hide critical data, while Citigroup
maintains that performance concerns predated that. Martin’s
attorney, Valdi Licul, plans to seek depositions from top bank
executives, including CEO Jane Fraser, to prove the retaliation
claim. Shares rose 0.5% in pre-market trading.
Nomura Holdings (NYSE:NMR) – Nomura analysts
recommend reducing investments in Chinese stocks and increasing
positions in Indonesia and Malaysia. They expect these markets to
benefit more from U.S. interest rate cuts, while Chinese stocks
face difficulties due to economic instability and the real estate
crisis.
KKR & Co. (NYSE:KKR) – KKR is exploring
options for Sylvan Inc., the world’s largest mushroom seed
producer, including bringing in new investors. KKR, with the help
of an advisor, is gauging interest in a yuan continuation fund.
However, discussions are in the early stages and may not result in
transactions.
MIRA Pharmaceuticals (NASDAQ:MIRA) – MIRA
Pharmaceuticals announced that its new ketamine analog, Ketamir-2,
reduced or reversed neuropathic pain in rats. The study showed that
low doses of Ketamir-2 provided substantial relief for up to 22
days, while higher doses completely normalized neuropathic pain,
something ketamine could not achieve. Shares rose 35.1% in
pre-market trading.
Talis Biomedical (NASDAQ:TLIS) – Nasdaq warned
that Talis Biomedical could be delisted for being considered a
“shell company.” Talis suspended all R&D activities in June and
is preparing for a bankruptcy filing. The company, which develops
molecular tests for infectious diseases, has cut 90% of its staff
and reduced operations in Chicago to conserve resources.
BioAffinity Technologies (NASDAQ:BIAF) –
BioAffinity Technologies appointed Michael Edwards as interim CFO
effective September 16, after CFO Michael Dougherty announced his
resignation to pursue new opportunities. Dougherty will remain
until September 16 to ensure a smooth transition. The company will
begin the search for a permanent CFO. Edwards, who has previously
served as CFO, was hired under a consulting contract with a monthly
salary of $10,000 plus expenses.
Eli Lilly (NYSE:LLY) – Eli Lilly’s early-stage
Alzheimer’s treatment, donanemab, is expected to be blocked by the
UK’s National Health Service (NHS), according to the Telegraph. The
National Institute for Health and Care Excellence (NICE) is
expected to reject the drug, citing concerns about costs and
monitoring side effects, as it did with lecanemab. Both drugs have
already been approved in the U.S.
Johnson & Johnson (NYSE:JNJ) – Johnson
& Johnson is negotiating with plaintiff attorneys who opposed
the $6.48 billion settlement over claims that its talc caused
cancer. The company is seeking additional support to finalize the
settlement through a subsidiary’s bankruptcy, ending lawsuits and
preventing new cases.
Novo Nordisk (NYSE:NVO) – With the U.S.
government negotiating drug prices for Medicare, the 2027 list is
expected to include Novo Nordisk’s Ozempic, along with drugs from
Pfizer, GSK, Teva, and AbbVie. While these negotiations could
impact some companies, many of the drugs already have significant
discounts, limiting the financial impact. Shares fell 0.7% in
pre-market trading.
Novartis (NYSE:NVS) – Novartis sold its PET
molecular imaging division to Siemens Healthineers for more than
$224 million. The transaction includes the diagnostics arm of
Advanced Accelerator Applications, acquired by Novartis in 2017.
The deal is expected to close in the fourth quarter.
JD com (NASDAQ:JD)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
JD com (NASDAQ:JD)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
